Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The falling incidence of hematologic cancer after heart transplantation.
Crespo-Leiro MG, Delgado-Jiménez J, López L, Alonso-Pulpón L, González-Vilchez F, Almenar-Bonet L, Rábago G, Pérez-Villa F, Paniagua Martín MJ, Arizón Del Prado JM, Sousa-Casasnovas I, Manito-Lorite N, Díaz-Molina B, Pascual-Figal D, Lage-Galle E, Blasco-Peiró T, De la Fuente-Galán L, Muñiz J. Crespo-Leiro MG, et al. Clin Transplant. 2014 Oct;28(10):1142-7. doi: 10.1111/ctr.12432. Epub 2014 Oct 1. Clin Transplant. 2014. PMID: 25100534
Malignancy after heart transplantation: incidence, prognosis and risk factors.
Crespo-Leiro MG, Alonso-Pulpón L, Vázquez de Prada JA, Almenar L, Arizón JM, Brossa V, Delgado JF, Fernandez-Yañez J, Manito N, Rábago G, Lage E, Roig E, Diaz-Molina B, Pascual D, Muñiz J. Crespo-Leiro MG, et al. Am J Transplant. 2008 May;8(5):1031-9. doi: 10.1111/j.1600-6143.2008.02196.x. Am J Transplant. 2008. PMID: 18416739 Free article.
The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry.
Crespo-Leiro MG, Alonso-Pulpón LA, Villa-Arranz A, Brossa-Loidi V, Almenar-Bonet L, González-Vilchez F, Delgado-Jiménez JF, Manito-Lorite N, Díaz-Molina B, Rábago G, Arizón-del Prado JM, Romero-Rodríguez N, Brossa V, Blasco-Peiró T, Pascual-Figal D, de la Fuente-Galán L, Muñiz-García J. Crespo-Leiro MG, et al. Transplant Proc. 2010 Oct;42(8):3011-3. doi: 10.1016/j.transproceed.2010.08.010. Transplant Proc. 2010. PMID: 20970595
Lung cancer after heart transplantation: results from a large multicenter registry.
Crespo-Leiro MG, Villa-Arranz A, Manito-Lorite N, Paniagua-Martin MJ, Rábago G, Almenar-Bonet L, Alonso-Pulpón L, Mirabet-Pérez S, Diaz-Molina B, González-Vilchez F, Arizón de Prado JM, Romero-Rodriguez N, Delgado-Jimenez J, Roig E, Blasco-Peiró T, Pascual-Figal D, De la Fuente Galán L, Muñiz J. Crespo-Leiro MG, et al. Am J Transplant. 2011 May;11(5):1035-40. doi: 10.1111/j.1600-6143.2011.03515.x. Am J Transplant. 2011. PMID: 21521471 Free article.
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
Kapelios CJ, Laroche C, Crespo-Leiro MG, Anker SD, Coats AJS, Díaz-Molina B, Filippatos G, Lainscak M, Maggioni AP, McDonagh T, Mebazaa A, Metra M, Moura B, Mullens W, Piepoli MF, Rosano GMC, Ruschitzka F, Seferovic PM, Lund LH; Heart Failure Long-Term Registry Investigators Group. Kapelios CJ, et al. Eur J Heart Fail. 2020 Aug;22(8):1424-1437. doi: 10.1002/ejhf.1796. Epub 2020 Apr 1. Eur J Heart Fail. 2020. PMID: 32237110 Free article.
Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T. Gonzalez-Vilchez F, et al. Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23. Int J Cardiol. 2014. PMID: 24309084
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.
Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH; Heart Failure Long-Term Registry Investigators. Kapelios CJ, et al. Eur J Heart Fail. 2019 Nov;21(11):1383-1397. doi: 10.1002/ejhf.1532. Epub 2019 Jun 18. Eur J Heart Fail. 2019. PMID: 31132222 Free article.
Effect of early conversion to everolimus together with prophylaxis with valganciclovir in the prevention of cytomegalovirus infection in heart transplant recipients.
Díaz Molina B, Velasco Alonso E, Lambert Rodríguez JL, Rodríguez Bernardo MJ, Rozado Castaño J, Padrón Encalada R, Martín Fernández M, Pun Chinchai F, Colunga Blanco S, García Campos A. Díaz Molina B, et al. Transplant Proc. 2015 Jan-Feb;47(1):130-1. doi: 10.1016/j.transproceed.2014.11.026. Transplant Proc. 2015. PMID: 25645790
Study of the renal function in nonrenal organ transplantation.
Diez Ojea B, Gago González E, Díaz Corte C, Díaz Molina B, Dieguez L, Ortega Suárez F, Alvarez Grande J. Diez Ojea B, et al. Transplant Proc. 2006 Nov;38(9):2985-8. doi: 10.1016/j.transproceed.2006.08.181. Transplant Proc. 2006. PMID: 17112881
105 results